Learning Objectives
Upon completion of this activity, participants should be able to:
Review data on the emergence of resistance mutations during antiretroviral therapy.
Discuss data from clinical trials of agents used in first-line regimens and the role of monotherapy in the management of HIV-infected patients.
Describe the results of recent studies of novel antiretroviral agents currently in development for the treatment of HIV.